It would appear as though even the smartest people in the industry have decided Strategy is dying. As of the time of writing, STRC trades at roughly $84 (−16% below par) and MSTR remains within striking range of 1x mNAV after retracing nearly −60% in less than a month. Anywhere

Two weeks ago, Apyx went through the most significant stress test since launching in February 2026 and scaling to as much as $500M in circulating supply. STRC posted its largest decline from par on record, apxUSD traded as low as $0.90 on secondary markets, and the protocol processed a